Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$224,948
in 1 filing, $225K under 10b5-1 plans

Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McFarlane Neil F. −$225K President and CEO sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2015-09-04 Mickle Christal M M VP Operations & Prod Dev Grant or award · Stock Option (right to buy) +220,000 220,000
2015-09-04 Mickle Travis C President & CEO Grant or award · Stock Option (right to buy) +220,000 220,000
2015-09-04 Mickle Travis C President & CEO Grant or award · Stock Option (right to buy) +25,000 25,000
2015-08-25 Tierney David S Director Grant or award · Stock Option (right to buy) +10,000 10,000
2015-08-25 Thompson Danny L Director Grant or award · Stock Option (right to buy) +10,000 10,000
2015-08-25 Saluri Joseph Director Grant or award · Stock Option (right to buy) +10,000 10,000
2015-08-25 Plooster Matthew R Director Grant or award · Stock Option (right to buy) +10,000 10,000
2015-08-25 Plooster Matthew R Director Grant or award · Stock Option (right to buy) +12,000 12,000
2015-08-25 Pascoe Richard W Director Grant or award · Stock Option (right to buy) +10,000 10,000
2015-06-25 Johnson Gordon K Chief Business Officer Grant or award · Stock Option (right to buy) +160,000 160,000
2015-06-25 Clifton R. LaDuane Chief Financial Officer Grant or award · Stock Option (right to buy) +45,000 45,000
2015-05-27 Johnson Gordon K COO & CFO Grant or award · Stock Option (right to buy) +88,000 88,000
2015-05-27 Woody Tracy M Chief Commercial Officer Grant or award · Stock Option (right to buy) +82,035 82,035
2015-04-21 Johnson Gordon K COO & CFO Purchase +2,000 $11.00 $22K 2,000
2015-04-21 Tierney David S Director Purchase +5,000 $11.00 $55K 5,000
2015-04-21 Thompson Danny L Director Conversion +7,373 7,373
2015-04-21 Thompson Danny L Director Conversion +91,687 91,687
2015-04-21 Thompson Danny L Director Conversion · Series A Convertible Preferred Stock −26,355 0
2015-04-21 Thompson Danny L Director Conversion · Series B Convertible Preferred Stock −16,129 0
2015-04-21 Thompson Danny L Director Conversion · Series C Convertible Preferred Stock −12,820 0

Page 23 of 25 · 499 trades